Sands Capital Global Venture Fund Ii, L.p.

ABOS

10% OWNER · ACUMEN PHARMACEUTICALS, INC. · CIK 0001870493

FILING MIX · LIFETIME60%/40%

BUYS

SELLS

TOTAL VALUE

$6.70M

COMPANIES

ACTIVE SINCE

Jul 2021

HOLDINGS NOW

2,967,075

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

1 backtested trades · 8 horizonsHow are these numbers computed? →

Forward-return performance of every backtestable P/S trade by Sands Capital Global Venture Fund Ii, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	1	+0.00%	-6.24%	+0.62%	-6.85%	-6.85%	—
14d	1	+0.00%	-8.37%	-0.43%	-7.93%	-7.93%	—
30d	1	+0.00%	-25.79%	+2.04%	-27.83%	-27.83%	—
60d	1	+0.00%	-22.82%	+4.65%	-27.48%	-27.48%	—
90d	1	+0.00%	-25.00%	-0.67%	-24.33%	-24.33%	—
180d	1	+0.00%	-66.68%	+11.09%	-77.77%	-77.77%	—
1y	1	+0.00%	-72.77%	-10.21%	-62.56%	-62.56%	—
2y	1	+0.00%	-75.00%	+4.69%	-79.69%	-79.69%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

ABOS · 2,967,075 shares · as of Jul 6, 2021

Trading cadence · quarterly flow

BUY ● SELL ●

2021

FLOW · 3 buys / 2 sellsCOVERAGE · 1 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
ABOS ACUMEN PHARMACEUTICALS, INC.	PURCHASE	1,124,729	—	—	1,124,729	Jul 6, 2021	Jul 8, 2021 ↗	View →
ABOS ACUMEN PHARMACEUTICALS, INC.	SALE	1,842,346	—	—	0	Jul 6, 2021	Jul 8, 2021 ↗	View →
ABOS ACUMEN PHARMACEUTICALS, INC.	SALE	1,124,729	—	—	0	Jul 6, 2021	Jul 8, 2021 ↗	View →
ABOS ACUMEN PHARMACEUTICALS, INC.	PURCHASE	450,000	$14.88	$6.70M	3,417,075	Jul 6, 2021	Jul 8, 2021 ↗	View →
ABOS ACUMEN PHARMACEUTICALS, INC.	PURCHASE	1,842,346	—	—	2,967,075	Jul 6, 2021	Jul 8, 2021 ↗	View →

Other insiders · ABOS

Loading peer insiders…

About this filer

CIK 0001870493

ROLE

10% Owner

PRIMARY

ABOS

COMPANIES

ACTIVE SINCE

Jul 2021

MARKETPEEL · /INSIDER/0001870493DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Sands Capital Global Venture Fund Ii, L.p.

The morning brief, before the bell.